Pharmacokinetics and Pharmacodynamics Flashcards

1
Q

Define pharmacokinetics vs pharmacodynamics

A

PK: study of how the organism affects the drug (ADME: absorption, distribution, metabolism, excretion)
PD: study of how the drug affects the organism (relationship of drug concentration and response)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

(ADME) What affects the Absorption of drugs?

A

rate of absorption is affected by:
1. route of administration (IV bolus> IV infusion > intramuscular > oral > oral extended release)
2. properties of drug: molecular weight and structure (typical drug: 100-1000 Da, solubility (partition coefficient increases as lipid solubility increases), ionization (most drugs are weak acid/bases; uncharged form can diffuse across membrane)
3. underlying physiology of patient: adherence or compliance (elderly and psychiatric), GI function for oral drugs (pH, gastric emptying, malabsorption, variable expression of GI drug transporters), physiological factors (age, gender, pregnant, obese), environment (other medications, herbal products, food, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

(ADME) Describe the distribution of drugs. What affects the distribution of drugs?

A

Drugs can be distributed from circulation to target tissue/rest of body. First goes to highly perfused organs (liver, kidney, brain) then to lesser ones (adipose, muscle, etc)

properties of the drug that affect distribution:
- protein* (acidic drugs bind to albumin, basic drugs bind to AAG; only free (unbound) drugs can produce pharmaco effect; high binding -> slower elimination, prolonged duration of action)
- molecular size and struct
- lipid solubility
- degree of ionization
- tissue perfusion
- movement across membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some considerations for effect of binding protein on free drug conc.

A

albumin levels can be decreased in liver diseases
AAG is acute phase reactant (elevated in inflammation)
co-administered drugs can compete for binding sites and result in higher free drug concentration; (increased free drug conc. = increased pharmacologic effect; may be over toxicity threshold)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define volume of distribution and why is it helpful

A

Volume of distribution is the theoretical volume of total body fluid which all of the drugs is distributed.
Anatomic Vd = total amount of drug in body/ initial plasma drug conc.
Apparent Vd = Anatomic Vd/ body weight

Volume of distribution can be helpful for 3 reasons:
- predicting where drug might be distributed (plasma vs tissue)
- predicting plasma drug concentration when dose administered is known
- deciding whether to use hemodialysis in poisonings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

(ADME) What is the result of metabolism on drugs (ie. how is it altered)? What are the responsible organs? how are the metabolisms categorized?

A

metabolism alters drugs to be more water soluble for excretion
- responsible organs: liver (main), kidneys, intestines, lungs, skin, eye
- categorized into: hepatic microsomal, non-microsomal, extra-hepatic

parent compounds are metabolized into metabolites (may or may not be active)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define bioavailability

A

bioavailability is the measure of the extent of absorption NOT the rate.
- measures the percentage of drug that enters the circulation in an unchanged form
- bioavailability over 70% is considered useful for oral drugs
- affected by first pass effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define the first pass effect

A

The first pass effect is the biotransformation of a drug before it reaches its site of action
(affects bioavailability)
- predominately occurs in liver (but can also occur in small intestine)
- drugs are absorbed from small intestine -> liver via hepatic portal vein -> metabolized by liver enzymes -> blood with parent compound + metabolites enter circulation by hepatic vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are 4 factors that affect biotransformation? describe induction vs inhibition on drug concentration

A

genetic polymorphisms (can increase or decrease enzyme act.)
physiological factors: age, gender, etc.
environmental factors: diet, medication, etc.
Drug-drug interactions can lead to enzyme induction (increased enzyme synthesis, increased metabolism of drug, decreased drug concentration) or enzyme inhibition (decreased enzyme synthesis, decreased metabolism, increased drug concentration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

(ADME) What are the routes of elimination of drugs?

A

Elimination routes:
Kidneys -> urine
Liver -> secreted into bile -> feces
breath, breast milk, saliva, sweat, tears, hair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

(ADME) What are some factors that affect renal and hepatic elimination of drugs

A

Perfusion and function of organs (renal function on glomerular filtration)
protein binding: free drugs get filtered by glomerulus; therefore bound drugs prolong half-life
urine pH and resorption in tubules: pH alters ionization and solubility of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the elimination half life? What is an assumption made? what does it determine?

A

elimination half life is the time it takes for the concentration to decrease by 50%
- assumes absorption and distribution phase are complete
- determines the length of drug effect
- sum of metabolism + excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the difference between potency and efficacy

A

potency: minimum dose to see expected results (higher potency, less drug needed to give a desired effect); measured using ED50 (dose needed to see effects in 50% of pop)
efficacy: maximal effects achievable (reflects how the drug works in ideal situations)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the difference between an agonist and an antagonist

A

Agonist binds to receptor to produce a biological response that mimics that of an endogenous ligand (can be a full agonist, partial agonist, or inverse agonist)
Antagonist binds to receptor but has no activity, can block endogenous ligand from binding (attenuates effect of agonists)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the therapeutic index? how is it calculated?

A

therapeutic index is the comparison of a drugs therapeutic effect vs toxic effect
TI =LD50/ED50
-higher the TI, the more separated the toxic effect and therapeutic effect are therefore safer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define therapeutic drug monitoring and its purpose

A

TDM: measurement of drug concentration in blood
Why?
to provide objective information to guide clinicians to achieve optimal treatment dosing
- allows individualized drug dosing (optimal dose for each patient)
- maximize therapeutic response
- minimize toxicity
- assess drug resistance
- pharmacogenetics

17
Q

describe the criteria used to determine whether a drug is suitable for TDM

A

Criteria includes:
- drug has a narrow TI
- large intra and inter individual differences in dose/response relationship
- serious consequence of under/overdosing
- potential for drug-drug interactions
- need accurate and specific assays to measure [drug]
- result of TDM is actionable
- relationship of [drug] in blood and toxicity must be defined

18
Q

Describe what is steady-state, MEC , MTC, therapeutic range, peak and tough concentrations

A

Steady-state: when drug input (dosing) = drug output (elimination) is when TDM is measured (between peak and trough)
MEC: minimum concentration that associates with therapeutic effect
MTC: minimum concentration that associates with toxic effects
therapeutic range: range between highest efficacy and lowest toxicity

19
Q

discuss factors in TDM interpretation (drug, patient, pre-anal, anal, other)

A

Drug: formulation, route of administration, ADME, half-life
Patient: age, gender, weight, renal and hepatic function…
Pre-analytical:
- collection tube: avoid gel barrier tubes, potential interferences with tube additive;
- time of last dose and collection: for drugs with short t1/2, both peak and trough are used, for long t 1/2, trough are used; wait 6-12 hours post dose before taking sample for drugs with prolonged distribution phase (digoxin)
Analytical:
- method of analysis (automated immunoassay, chromatographic based)
total vs free drugs: most TDM assays measure total drug; when protein concentration changes (ie. in pregnancy, liver disease, renal disease), measuring free drug is better
Prodrug vs parent drug vs metabolite: different method of analysis may recognize diff form.

20
Q

In what cases might drugs meet TDM criteria but measurement of administered drug is not useful?

A

in cases where a prodrug is administered (metabolite is the active form)
or drugs that develop tolerance (effective [drug] is a moving target and not stable within patient)